The Oncology Institute Inc
(NAS:TOI)
$
0.2999
0.0115 (3.99%)
Market Cap: 22.64 Mil
Enterprise Value: 96.46 Mil
PE Ratio: 0
PB Ratio: 0.75
GF Score: 40/100 Oncology Institute Inc at UBS Global Healthcare Conference Transcript
May 24, 2022 / 02:00PM GMT
Release Date Price:
$8.43
(-6.12%)
Andrew Mok
UBS Investment Bank, Research Division - Analyst
Hi. Good morning, and welcome back to the UBS Healthcare Conference. My name is Andrew Mok. I'm the health care providers analyst at UBS. And joining me on stage is CEO of the Oncology Institute. Brad, welcome to -- Brad Hively. Brad, welcome to the stage and welcome to the UBS Healthcare Conference.
Bradford D. Hively
The Oncology Institute, Inc. - CEO & Director
Thanks, Andrew. It's a pleasure to be here with you. I appreciate the invite and the interest.
Andrew Mok
UBS Investment Bank, Research Division - Analyst
Absolutely. And Brad, to start, why don't you give us a little bit of background on the company and help us understand how you're differentiated versus a traditional oncology practice.
Bradford D. Hively
The Oncology Institute, Inc. - CEO & Director
Yes, sure. So TOI is a large community oncology group, and we're the nation's leading value-based oncology group. So what that means is we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot